Toxicity of Ethanol in Low Concentrations

References

• Berry M. N., Friend D. S. High-yield preparation of isolated rat liver parenchymal cells. J. Cell Biol. 1969; 43: 506
   PubMed Web of Science ®Google Scholar
• Castrén-Persons M., Schröder T., Rämö O. J., Puolakkainen P., Lehtonen E. Contact Nd: YAG laser potentiates the tumor killing effect of hyperthermia. Lasers Surg. Med. 1991; 11: 595
   PubMed Web of Science ®Google Scholar
• Giorgio A., Tarantino L., Francica G., Scala V., Mariniello N., Aloisio T. Percutaneous ethanol injection under sonographic guidance of hepatocellular carcinoma in compensated and decompensated cirrhotic patients. J. Ultrasound Med. 1992; 11: 587
   PubMedGoogle Scholar
• Isobe H., Fukai T., Iwamoto H., et al. Liver abscess complicating intratumoral ethanol injection therapy for HCC. Am. J. Gastroenterol. 1990; 85: 1646
   PubMed Web of Science ®Google Scholar
• Koda M., Okamoto K., Miyoshi Y., Kawasaki H. Hepatic vascular and bile duct injury after ethanol injection therapy for hepatocellular carcinoma. Gastrointest. Radiol. 1992; 17: 167
   PubMedGoogle Scholar
• Komiyama K., Takekuma Y., Nekohashi T., Abe T., Satoi J. Fluoroscopic contrast medium percutaneous ethanol injection therapy (FCM-PEIT). Newly developed clinically useful method for injecting ethanol into nodules of hepatocellular carcinoma. (Abstract.). Nippon Shokakibyo Gakkai Zasshi 1994; 91: 162
   Google Scholar
• Kotoh K., Sakai H., Sakamoto S., et al. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am. J. Gastroenterol. 1994; 89: 194
   PubMed Web of Science ®Google Scholar
• Kurki P., Laasonen A., Tan E. M., Lehtonen E. Cell proliferation and expression of cytokeratin filaments in F9 embryonal carcinoma cells. Development 1989; 106: 635
   Google Scholar
• Lehtonen E., Laasonen A., Tienari J. Teratocarcinoma stem cells as a model for differentiation in the mouse embryo. Int. J. Dev. Biol. 1989; 33: 105
   Google Scholar
• Lehtonen E., Lehto V. P., Vartio T., Badley R. A., Virtanen I. Expression of cytokeratin polypeptides in mouse oocytes and preimplantation embryos. Dev. Biol. 1983; 100: 158
   Google Scholar
• Lindros K. O., Penttilå K. E. Digitonin-collagenase perfusion for efficient separation of periportal or perivenous hepatocytes. Biochem. J. 1985; 228: 757
   PubMed Web of Science ®Google Scholar
• Livraghi T., Festi D., Monti F., Salmi A., Vettori C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986; 161: 309
   PubMed Web of Science ®Google Scholar
• Livraghi T., Salmi A., Bolondi L., et al. Small hepatocellular carcinoma. Percutaneous alcohol injection - results in 23 patients. Radiology 1988; 168: 313
   PubMed Web of Science ®Google Scholar
• Livraghi T., Vettori C., Lazzaroni S. Liver metastasis. Results of percutaneous ethanol injection in 14 patients. Radiology 1991; 179: 709
   PubMedGoogle Scholar
• Redvanly R., Chezmar J., Strauss R., Galloway J., Boyer T., Bernardino M. Malignant hepatic tumors. Safety of high-dose percutaneous ethanol ablation therapy. Radiology 1993; 188: 283
   PubMedGoogle Scholar
• Salim A. S. Chemonecrosis for localized dynamic destruction of hepatic metastases of colonic cancer. Oncology 1993; 50: 18
   Google Scholar
• Sheu J. C., Sung J. L., Huang G. T., et al. Intratumoral injection of absolute ethanol under ultrasound guidance for the treatment of small hepatocellular carcinoma. Hepatogastroenterology 1987; 34: 255
   PubMedGoogle Scholar
• Shiina S., Tagawa K., Niwa Y., et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. Results in 146 patients. Am. J. Roentgenol. 1993; 160: 1023
   PubMedGoogle Scholar
• Shiina S., Tagawa K., Unuma T., et al. Percutaneous ethanol injection therapy for neoplasms located on the surface of the liver. Am. J. Roentgenol. 1990; 155: 507
   PubMedGoogle Scholar
• Shiina S., Tagawa K., Unuma T., Terano A. Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma. Am. J. Roentgenol. 1990; 154: 947
   PubMed Web of Science ®Google Scholar
• Shiina S., Yasuda H., Muto H., et al. Percutaneous ethanol injection in the treatment of liver neoplasms. Am. J. Roentgenol. 1987; 149: 949
   PubMed Web of Science ®Google Scholar
• Solinas A., Erbella G., Distrutti E., et al. Abscess formation in hepatocellular carcinoma. Complications of percutaneous ultrasound-guided ethanol injection. J. Clin. Ultrasound 1993; 21: 531
   PubMedGoogle Scholar
• Taavitsainen M., Vehmas T., Kauppila R. Fatal liver necrosis following percutaneous ethanol injection for hepatocellular carcinoma. Abdom. Imaging 1993; 18: 357
   PubMedGoogle Scholar
• Tanaka K., Okazaki H., Nakamura S., et al. Hepatocellular carcinoma. Treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection. Radiology 1991; 179: 713
   PubMed Web of Science ®Google Scholar
• Tapani E., Vehmas T., Taavitsainen M. Ultrasound monitoring of experimental ethanol injection into pig liver. Acad. Radiol. 1994; 1: 21
   Google Scholar
• Tienari J., Lehtonen E., Vartio T., Virtanen I. Embryonal carcinoma cells adhere preferentially to fibronectin and laminin but their endodermal differentiation leads to reduced adherence to laminin. Exp. Cell Res. 1989; 182: 26
   Google Scholar
• Tienari J., Pertovaara L., Saksela O., Lehtonen E., Vartio T. Increased expression of the matrix metalloproteinase 2 in differentiating Tera 2 human embryonal carcinoma cells. Int. J. Cancer 1994; 56: 219
   Google Scholar
• Tienari J., Virtanen I., Soinila S., Lehtonen E. Neuron-like derivates of cultured F9 embryonal carcinoma cells express characteristics of parietal endoderm cells. Dev. Biol. 1987; 123: 566
   PubMed Web of Science ®Google Scholar
• Vehmas T., Tapani E. Echogenicity of experimental liver ethanol injections. Ultrasound Med. Biol. 1995; 21: 1137
   Google Scholar